Skip to content
Screener

Beta Bionics BBNX Return on invested capital

Return on invested capital at other companies

Insulet logo
InsuletPODD
19.3%0.0pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-6.9%-3.0pp
Medtronic logo
MedtronicMDT
6.7%+0.1pp
Embecta Corp. logo
Embecta Corp.EMBC
24.3%-10.3pp
AdaptHealth logo
AdaptHealthAHCO
0.7%-3.9pp
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
34.1%+10.7pp

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%
P/S-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%
Debt / equity0.0×
Current ratio8.9×-5.8×

Where this comes from

Calculated from Beta Bionics’s reported figures.

Based on trailing twelve months.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777

FAQ

What is Beta Bionics's return on invested capital?
Beta Bionics (BBNX) reported return on invested capital of -33.8% in Q2 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Ask your AI about Beta Bionics's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude